Defective Product Sales Cost GlaxoSmithKline $750 Million

An article published by the New York Times speaks of the $750 million settlement the British drug company GlaxoSmithKline has agreed to pay to end a number of civil and criminal complaints regarding knowingly defective medicines they put on store shelves for years. Such defective products include contaminated diaper cream, and an inaffective antidepressant. Twenty other medicines were sold with "questionable safety," including the diabetes drug Avandia, the heart drug Corteg, and the acid reflux drug Tagamet. The article goes on to say: "[New lawsuits] have asserted that drug makers misled patients and defrauded federal and state … [Read more...]